Biodexa Pharmaceuticals Plc

DB:5MP0 주식 보고서

시가총액: €4.0m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Biodexa Pharmaceuticals 관리

관리 기준 확인 4/4

Biodexa Pharmaceuticals' CEO is Stephen Stamp, appointed in Sep 2019, has a tenure of 3.58 years. total yearly compensation is £237.90K, comprised of 99.4% salary and 0.6% bonuses, including company stock and options. directly owns 0.003% of the company’s shares, worth €105.82. The average tenure of the management team and the board of directors is 2.3 years and 6 years respectively.

주요 정보

Stephen Stamp

최고 경영자

UK£237.9k

총 보상

CEO 급여 비율99.4%
CEO 임기3.6yrs
CEO 소유권0.003%
경영진 평균 재임 기간2.3yrs
이사회 평균 재임 기간6yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Stephen Stamp 의 보수는 Biodexa Pharmaceuticals 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2022n/an/a

-UK£5m

Mar 31 2022n/an/a

-UK£5m

Dec 31 2021UK£329kUK£187k

-UK£5m

Sep 30 2021n/an/a

-UK£7m

Jun 30 2021n/an/a

-UK£8m

Mar 31 2021n/an/a

-UK£15m

Dec 31 2020UK£193kUK£175k

-UK£22m

Jun 30 2020n/an/a

-UK£22m

Mar 31 2020n/an/a

-UK£16m

Dec 31 2019UK£207kUK£50k

-UK£9m

보상 대 시장: Stephen's total compensation ($USD296.50K) is below average for companies of similar size in the German market ($USD444.06K).

보상과 수익: Stephen's compensation has been consistent with company performance over the past year.

CEO

Stephen Stamp (60 yo)

3.6yrs

테뉴어

UK£237,897

보상

Mr. Stephen A. Stamp serves as Chief Financial Officer and Director of Biodexa Pharmaceuticals Plc (formerly known as Midatech Pharma plc) since September 9, 2019. He serves as Chief Executive Officer at B...

리더십 팀

이름위치테뉴어보상소유권
Stephen Stamp
CEO, CFO3.6yrsUK£237.90k0.0026%
£ 105.8
Dmitry Zamoryakhin
Chief Scientific Officer1.8yrsUK£236.68k데이터 없음
Daniel Palmer
Vice President of Technology2.3yrs데이터 없음데이터 없음
Vincent Holmes
VP & Head of Clinical Operationsless than a year데이터 없음데이터 없음
David Benharris
President of Midatech Pharma US Inc7.3yrs데이터 없음데이터 없음
Fiona Sharp
Group Financial Controllerno data데이터 없음데이터 없음

2.3yrs

평균 재임 기간

57yo

평균 연령

경험이 풍부한 관리: 5MP0's management team is considered experienced (2.3 years average tenure).

이사회 구성원

이름위치테뉴어보상소유권
Stephen Stamp
CEO, CFO3.6yrsUK£237.90k0.0026%
£ 105.8
Simon Turton
Senior Independent Non-Executive Director8.3yrsUK£31.54k0.0029%
£ 117.0
Stephen Parker
Non-Executive Chairmanless than a yearUK£43.84k데이터 없음
Daniel McCurdy
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Sijmen de Vries
Independent Non-Executive Director18.5yrsUK£31.54k0.0012%
£ 49.7
Michael Natan
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Francesco Stellaci
Chairman of Scientific Advisory Boardno data데이터 없음데이터 없음
David Male
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Lorraine O'Driscoll
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Soledad Penades
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Jean-Christophe Roux
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Silke Krol
Member of Scientific Advisory Boardno data데이터 없음데이터 없음

6.0yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 이사회: 5MP0's board of directors are considered experienced (6 years average tenure).